Renal osteodystrophy may present with a wide spectrum of bone lesions, rang
ing from high bone turnover to low bone turnover. Decreased serum calcium a
nd 1,25-dihydroxy Vitamin D synthesis and retention of phosphate are involv
ed in the pathogenesis of high bone turnover. However, several factors may
influence the evolution of this disorder. The use of different therapeutic
approaches (such as calcium supplements, phosphate binders, vitamin D metab
olites, etc.), the type of treatment (either hemodialysis or continuous amb
ulatory peritoneal dialysis), and also the changes in the type of patients
to whom we are offering dialysis (more diabetics and older patients are cur
rently included in dialysis programs) may have introduced changes modifying
the form of presentation of the bone metabolic disorders. As a result, rec
ent studies reported a greater prevalence of adynamic forms of renal osteod
ystrophy. Patients with adynamic bone (with or without aluminum) would have
more difficulties in handling and buffering calcium loads; consequently, t
hey would have a higher risk of extraosseous calcifications.